Search Results - "Banerjee, Sushanta"

Refine Results
  1. 1

    MIND model for triple-negative breast cancer in syngeneic mice for quick and sequential progression analysis of lung metastasis by Ghosh, Arnab, Sarkar, Sandipto, Banerjee, Snigdha, Behbod, Fariba, Tawfik, Ossama, McGregor, Douglas, Graff, Stephanie, Banerjee, Sushanta K

    Published in PloS one (29-05-2018)
    “…Mouse models of breast cancer with specific molecular subtypes (e.g., ER or HER2 positive) in an immunocompetent or an immunocompromised environment…”
    Get full text
    Journal Article
  2. 2

    Aspirin blocks growth of breast tumor cells and tumor-initiating cells and induces reprogramming factors of mesenchymal to epithelial transition by Maity, Gargi, De, Archana, Das, Amlan, Banerjee, Snigdha, Sarkar, Sandipto, Banerjee, Sushanta K

    Published in Laboratory investigation (01-07-2015)
    “…Acetylsalicylic acid (ASA), also known as aspirin, a classic, nonsteroidal, anti-inflammatory drug (NSAID), is widely used to relieve minor aches and pains and…”
    Get full text
    Journal Article
  3. 3

    Emblica officinalis extract induces autophagy and inhibits human ovarian cancer cell proliferation, angiogenesis, growth of mouse xenograft tumors by De, Alok, De, Archana, Papasian, Chris, Hentges, Shane, Banerjee, Snigdha, Haque, Inamul, Banerjee, Sushanta K

    Published in PloS one (15-08-2013)
    “…Patients with ovarian cancer (OC) may be treated with surgery, chemotherapy and/or radiation therapy, although none of these strategies are very effective…”
    Get full text
    Journal Article
  4. 4

    Protein PEGylation for cancer therapy: bench to bedside by Gupta, Vijayalaxmi, Bhavanasi, Sneha, Quadir, Mohiuddin, Singh, Kevin, Ghosh, Gaurav, Vasamreddy, Kritin, Ghosh, Arnab, Siahaan, Teruna J., Banerjee, Snigdha, Banerjee, Sushanta K.

    “…PEGylation is a biochemical modification process of bioactive molecules with polyethylene glycol (PEG), which lends several desirable properties to…”
    Get full text
    Journal Article
  5. 5

    The miRacle in Pancreatic Cancer by miRNAs: Tiny Angels or Devils in Disease Progression by Hawa, Zuhair, Haque, Inamul, Ghosh, Arnab, Banerjee, Snigdha, Harris, LaCoiya, Banerjee, Sushanta K

    “…Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with increasing incidence and high mortality. Surgical resection is the only potentially…”
    Get full text
    Journal Article
  6. 6

    Leptin-induced ER-α-positive breast cancer cell viability and migration is mediated by suppressing CCN5-signaling via activating JAK/AKT/STAT-pathway by Haque, Inamul, Ghosh, Arnab, Acup, Seth, Banerjee, Snigdha, Dhar, Kakali, Ray, Amitabha, Sarkar, Sandipto, Kambhampati, Suman, Banerjee, Sushanta K

    Published in BMC cancer (25-01-2018)
    “…In menopausal women, one of the critical risk factors for breast cancer is obesity/adiposity. It is evident from various studies that leptin, a 16 kDa protein…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Deficiency of CCN5/WISP-2-Driven Program in breast cancer Promotes Cancer Epithelial cells to mesenchymal stem cells and Breast Cancer growth by Das, Amlan, Dhar, Kakali, Maity, Gargi, Sarkar, Sandipto, Ghosh, Arnab, Haque, Inamul, Dhar, Gopal, Banerjee, Snigdha, Banerjee, Sushanta K.

    Published in Scientific reports (27-04-2017)
    “…Breast cancer progression and relapse is conceivably due to tumor initiating cells (TICs)/cancer stem cells. EMT (epithelial-mesenchymal-transition)-signaling…”
    Get full text
    Journal Article
  9. 9

    Short-term soy isoflavone intervention in patients with localized prostate cancer: a randomized, double-blind, placebo-controlled trial by Hamilton-Reeves, Jill M, Banerjee, Snigdha, Banerjee, Sushanta K, Holzbeierlein, Jeffrey M, Thrasher, J Brantley, Kambhampati, Suman, Keighley, John, Van Veldhuizen, Peter

    Published in PloS one (12-07-2013)
    “…We describe the effects of soy isoflavone consumption on prostate specific antigen (PSA), hormone levels, total cholesterol, and apoptosis in men with…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Cyr61/CCN1 signaling is critical for epithelial-mesenchymal transition and stemness and promotes pancreatic carcinogenesis by Haque, Inamul, Mehta, Smita, Majumder, Monami, Dhar, Kakali, De, Archana, McGregor, Douglas, Van Veldhuizen, Peter J, Banerjee, Sushanta K, Banerjee, Snigdha

    Published in Molecular cancer (13-01-2011)
    “…Despite recent advances in outlining the mechanisms involved in pancreatic carcinogenesis, precise molecular pathways and cellular lineage specification…”
    Get full text
    Journal Article
  12. 12

    Downregulation of miR-506-3p Facilitates EGFR-TKI Resistance through Induction of Sonic Hedgehog Signaling in Non-Small-Cell Lung Cancer Cell Lines by Haque, Inamul, Kawsar, Hameem I, Motes, Hannah, Sharma, Mukut, Banerjee, Snigdha, Banerjee, Sushanta K, Godwin, Andrew K, Huang, Chao H

    “…Non-small-cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutation eventually develop resistance to EGFR-targeted tyrosine…”
    Get full text
    Journal Article
  13. 13

    The role of CCNs in controlling cellular communication in the tumor microenvironment by Birkeness, Lauren B., Banerjee, Snigdha, Quadir, Mohiuddin, Banerjee, Sushanta K.

    “…The Cellular communication network (CCN) family of growth regulatory factors comprises six secreted matricellular proteins that promote signal transduction…”
    Get full text
    Journal Article
  14. 14

    Boron chemicals in diagnosis and therapeutics by Das, Bhaskar C, Thapa, Pritam, Karki, Radha, Schinke, Caroline, Das, Sasmita, Kambhampati, Suman, Banerjee, Sushanta K, Van Veldhuizen, Peter, Verma, Amit, Weiss, Louis M, Evans, Todd

    Published in Future medicinal chemistry (01-04-2013)
    “…Advances in the field of boron chemistry have expanded the application of boron from material use to medicine. Boron-based drugs represent a new class of…”
    Get more information
    Journal Article
  15. 15
  16. 16
  17. 17

    The Role of Compounds Derived from Natural Supplement as Anticancer Agents in Renal Cell Carcinoma: A Review by Haque, Inamul, Subramanian, Arvind, Huang, Chao H, Godwin, Andrew K, Van Veldhuizen, Peter J, Banerjee, Snigdha, Banerjee, Sushanta K

    “…Renal Cell Carcinoma (RCC) is the most prominent kidney cancer derived from renal tubules and accounts for roughly 85% of all malignant kidney cancer. Every…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20